Prospective Tissue Collection Research Protocol

Trial Identifier: ATX-MAP-001
Sponsor: AstraZeneca
Start Date: February 2018
Primary Completion Date: October 2024
Study Completion Date: October 2024
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Spain Barcelona, Spain, 08908
Spain Barcelona, Spain, 08036
Spain Madrid, Spain, 28040
Spain Madrid, Spain, 28050
United Kingdom Glasgow, United Kingdom, G51 4TF
United Kingdom Leeds, United Kingdom, LS9 7TF
United Kingdom London, United Kingdom, NW1 2PG
United Kingdom London, United Kingdom, SW3 6JJ
United Kingdom London, United Kingdom, SE1 9RT
United Kingdom London, United Kingdom, NW3 2QG,
United Kingdom London, United Kingdom, SW3 6NP
United Kingdom Manchester, United Kingdom, M23 9LT
United Kingdom Newcastle Upon Tyne, United Kingdom, NE7 7DN
United Kingdom Southampton, United Kingdom, SO16 6YD
United Kingdom Uxbridge, United Kingdom, UB9 6JH
United States, New York New York, United States, 10065
United States, North Carolina Durham, North Carolina, United States, 27710
United States, Washington Georgetown, Washington, United States, 20057